Giovanna Polcaro

Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series

A. Ottaiano, M. Cascella, Luigi Liguori, 2023, Biomedicines.

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

G. Corbi, G. Nassa, G. Giurato, 2024, Molecular cancer.

Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors.

E. Novellino, P. Seneci, B. Pagano, 2021, Journal of medicinal chemistry.

Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy

G. Corbi, Federica De Rosa, Berenice Stefanelli, 2024, Journal of personalized medicine.

Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients

S. Pepe, C. Vecchione, V. Conti, 2021, Life.